Pages that link to "Q34270677"

The following pages link to An update on dual Src/Abl inhibitors (Q34270677):

Displaying 19 items.

• c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson's Disease (Q28070292) (← links)
• Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-Synucleinopathy (Q35019131) (← links)
• The importance of Src signaling in sarcoma (Q35802929) (← links)
• Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis. (Q36339714) (← links)
• Nilotinib-Induced Keratosis Pilaris (Q36906387) (← links)
• In silico profiling for secondary metabolites from Lepidium meyenii (maca) by the pharmacophore and ligand-shape-based joint approach (Q37286158) (← links)
• Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src (Q37362851) (← links)
• Novel approaches to the development of tyrosine kinase inhibitors and their role in the fight against cancer (Q38167808) (← links)
• Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances (Q38554422) (← links)
• Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis (Q38752798) (← links)
• Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors (Q38823850) (← links)
• Incorporating prior information into differential network analysis using non-paranormal graphical models (Q38838330) (← links)
• Tyrosine kinase inhibition increases functional parkin-Beclin-1 interaction and enhances amyloid clearance and cognitive performance (Q42003730) (← links)
• The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. (Q47714809) (← links)
• Blocking the bFGF/STAT3 interaction through specific signaling pathways induces apoptosis in glioblastoma cells (Q48645834) (← links)
• Theoretical Studies on Pyrazolo[3,4-d]pyrimidine Derivatives as Potent Dual c-Src/Abl Inhibitors Using 3D-QSAR and Docking Approaches. (Q53611498) (← links)
• Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors (Q58696684) (← links)
• Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration. (Q64938069) (← links)
• The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma (Q91723484) (← links)